21. Immunohematologic disorders

Journal of Allergy and Clinical Immunology

Volumn 111, Issue 2 SUPPL. 2, 2003, Pages

  Trivedi, Deepa H ^a   Bussel, James B ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Allo immune thrombocytopenia; Autoimmune hemolytic anemia; Autoimmune neutropenia; Drug induced thrombocytopenia; Hemolytic diseases of the newborn; ITP; IV gammaglobulin; Neonatal alloimmune neutropenia; Platelets; Transfusion reactions; TTP

Indexed keywords

ANTIBODY; AZATHIOPRINE; BLOOD CLOTTING FACTOR; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DANAZOL; ERYTHROPOIETIN; GAMMA GLOBIN; IMMUNOGLOBULIN; IMMUNOLOGIC AGENT; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY CD20; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THROMBIN INHIBITOR; UNCLASSIFIED DRUG; VINCRISTINE;

AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNITY; BLEEDING; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; FETUS DISEASE; HEMATOLOGIC DISEASE; HUMAN; IMMUNE DEFICIENCY; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; NEUTROPENIA; PLACENTAL TRANSFER; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; SPLENECTOMY; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0037323547     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.157     Document Type: Review

References (52)

1. Strobl FJ, Silberstein L. Immune-mediated anemia. In: Rich RR, Fleisher TA, Shearer WT, Schroeder HW Jr, Kotzin BL, editors. Clinical immunology: principles and practice. 2nd ed. London: Mosby; 2001. p. 72.1-11.
2. Bussel JB. Fc receptor blockade and immune thrombocytopenic purpura. Semin Hematol 2000;37:261-6.
3. Gehrs B, Friedberg R. Autoimmune hemolytic anemia. Am J Hematol 2002;69:258-71.
4. Sokol RJ, Hewitt S, Stamps BK. Autoimmune hemolysis: an 18-year study of 865 cases referred to a regional transfusion centre. Br Med J 1981;282:2023-7.
5. Petz LD, Garratty G. Acquired immune hemolytic anemias. New York: Churchill Livingstone; 1980.
6. Heddle NM. Acute paroxysmal cold hemoglobinuria. Transfus Med Rev 1989;3:219-29.
7. Mueller-Eckhardt C, Salama A. Drug-induced immune cytopenias: a unifying pathogenetic concept with special emphasis on the role of drug metabolites. Transfus Med Rev 1990;4:69-77.
8. Petz LD. Treatment of autoimmune hemolytic anemia. Curr Opin Hematol 2001;8:411-6.
9. Ahrens N, Kingreen D, Seltsam A, Salama A. Treatment of refractory autoimmune hemolytic anemia with anti-CD 20 (rituximab). Br J Haematol 2001;114:244-5.
10. Flores G, Cunningham-Rundles C, Newland AC, Bussel JB. Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia. Results in 73 patients. Am J Hematol 1993;44:237-42.
11. Kutti J, Wadenvik H, Safai-Kutti S, Bjorkander J, Hanson LA. Westberg G, et al. Successful treatment of refractory autoimmune hemolytic anemia by plasmapheresis. Scand J Haematol 1984;32:149-52.
12. Moise KJ Jr. Non-anti-D antibodies in red-cell alloimmunization. Eur J Obstet Gynecol Reprod Biol 2000;92:75-81.
13. Geifman-Holtzman O, Wojtowycz M, Kosmas E, Artal R. Female alloimmunization with antibodies known to cause hemolytic disease. Obstet Gynecol 1997;89:272-5.
14. Moise KJ Jr. Management of rhesus alloimmunization in pregnancy. Obstet Gynecol 2002;100:600-11.
15. Oepkes D. Invasive versus non-invasive testing in red-cell alloimmunized pregnancies. Euro J Obstet Gynecol Reprod Biol 2000;92:83-9.
16. Bux J, Behrens G, Jaeger G, Welte K. Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood 1998;91:181-6.
17. Bussel J, Lalezari P, Hilgartner M, Partin J, Fikrig S. O'Malley J, et al. Reversal of neutropenia with intravenous gamma-globulin in autoimmune neutropenia of infancy. Blood 1983;62:398-400.
18. Rodwell R, Gray P, Taylor K, Minchinton R. Granulocyte colony-stimulating factor treatment for alloimmune neonatal neutropenia. Arch Dis Child 1996;75:F57-8.
19. Gilmore M, Stroncek D, Korones D. Treatment of alloimmune neonatal neutropenia with granulocyte colony-stimulating factor. J Pediatr 1994;125:948-51.
20. Levine D, Madyastha P. Isoimmune neonatal neutropenia. Am J Perinatol 1986;3:231-3.
21. Rios E, Heresi G, Arevalo M. Familial alloimmune neutropenia of NA2 specificity. Am J Pediatr Hematol Oncol 1991;13:296-9.
22. Hanada T, Shin R, Hosoi M, Saito K, Takita H. Intravenous gamma-globulin in treatment of isoimmune neonatal neutropenia. Eur J Pediatr 1988;148:218-9.
23. McCrae KR, Bussel JB, Mannucci PM, Remuzzi G, Cines DB. Platelets: an update on diagnosis and management of thrombocytopenic disorders. Hematology 2001:282-305.
24. Nugent DJ. Childhood immune thrombocytopenic purpura. Blood Rev 2002;16:27-9.
25. Adams JR, Nathan DP, Bennet CL. Pharmacoeconomics of therapy for ITP: steroids, IVIG anti-D, and splenectomy. Blood Rev 2002;16:65-7.
26. Corcione F, Esposito C, Cuccurullo D, Settembre A, et al. Technical standardization of laparoscopic splenectomy: experience with 105 cases. Surg Endosc 2002;16:972-4.
27. Bussel JB. Novel approaches to refractory immune thrombocytopenic purpura. Blood Rev 2002;16:31-6.
28. George JN, Raskob GE, Shah SR, Rizvi MA, Hamilton SA, Osborne S, et al. Drug induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med 1998;1129:886-90.
29. Mueller-Eckhardt C, Salama A. Drug-induced cytopenias: a unifying pathogenetic concept with special emphasis on the role of drug metabolites. Transfus Med Rev 1990;4:69-77.
30. Chong BH, Du XP, Bemdt MC, Hom S, Chesterman CN. Characterization of the binding domains on platelet glycoproteins Ib-IX and IIb/IIIa complexes for the quinine/quinidine-dependent antibodies. Blood 1991;77:2190-9.
31. Suh JS, Aster RH, Visentin GP. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis recognize different epitopes on heparin-platelet factor 4. Blood 1998;91:916-22.
32. Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost 1998;79:1-7.
33. Warkentin TE, Kelton JG. Interaction of heparin with platelets, including heparin-induced thrombocytopenia. In: Bounameaux H, editor. Low molecular weight heparins in prophylaxis and therapy of thromboembolic diseases. New York: Marcel Dekker; 1994.
34. Hackett T, Kelton JG, Powers P. Drug induced platelet destruction. Semin Thromb Hemostat 1982;8:116-37.
35. Mueller-Eckhardt C, Keefel V. High dose IgG for post-transfusion purpura revisited. Br J Haematol 1988;57:163-7.
36. Kaplan C. Alloimmune thrombocytopenia of the fetus and the newborn. Blood Rev 2002;16:69-72.
37. Zheng X, Majerus EM, Sadler JE. ADAMTS13 and TTP. Curr Opin Hematol 2002;9:389-94.
38. Linden JV, Paul B, Dressler KP. A report of 104 transfusion errors in New York State. Transfusion 1992;32:601-6.
39. Davenport RD, Strileler RM, Kunkel SL. Red cell ABO incompatibility and production of tumor necrosis factor-alpha. Br J Haematol 1991;78:540-4.
40. Uhlmann EJ, Isgriggs E, Wallhermfechtel M, Goodnough LT. Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions. Transfusion 2001;41:997-1000.
41. Heddle NM, Klama L, Singer J, Richards C, Fedak P, Walker I, et al. The role of plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994;331:625-84.
42. Aye MT, Palmer DS, Giulivi A, Hashemi S. Effect of filtration of platetet concentrates on the accumulation of cytokines and platelet release factors during storage. Transfusion 1995;35:117-24.
43. Wang SE, Lara PN Jr, Lee-Ow A, Reed J, Wang LR, Palmer P, et al. Acetaminophen and diphenhydramine as premedication for platelet transfusions: a prospective randomized double-blinded placebo-controlled trial. Am J Hematol 2002;70:191-4.
44. Sandler SG, Mallory D, Malamut D, Eckrich R. IgA anaphylactic transfusion reactions. Transfus Med Rev 1995;9:1-8.
45. Popovsky MA, Moore SB. Diagnostic and pathogenic considerations in transfusion-related acute lung injury. Transfusion 1985;25:573-7.
46. Popovsky MA. Transfusion-related acute lung injury. Curr Opin Hematol 2000;7:402-7.
47. Thaler M, Shamiss A, Orgad S, Huszar M, Nussinovitch N, Meisel S, et al. The role of blood from the HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease after open heart surgery. N Engl J Med 1989;321:25-8.
48. Przepiorka D, LeParc GF, Stovall MA, Werch J, Lichtiger B. Use of irradiated blood components: practice parameter. Am J Clin Pathol 1996;106:6-11.
49. Ehrenforth S, Kreuz W, Scharrer I, Linde R, Funk M, Gungor T, et al. Incidence of development of factor VIII and factor IX inhibitors in hemophiliacs. Lancet 1992;339:594-8.
50. Setty YN, Komatireddy GR. Antiphospholipid antibodies in systemic lupus erythematosus and the antiphosphoplipid syndrome. Front Biosci 2001;6:E207-12.
51. Farquharson RG, Quenby S, Greaves M. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 2002;100:408-13.
52. Uthman IW, Gharavi AE. Viral infections and antiphospholipid antibodies. Semin Arthritis Rheum 2002;31:256-63.